Factors predicting poor survival after resection of stage IA non-small cell lung cancer

被引:68
作者
Chang, Michael Y.
Mentzer, Steven J.
Colson, Yolonda L.
Linden, Philip A.
Jaklitsch, Michael T.
Lipsitz, Stuart R.
Sugarbaker, David J.
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Thorac Surg, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Boston VA Healthcare, Boston, MA 02115 USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Thorac Surg, Boston, MA 02115 USA
[4] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Surg & Publ Hlth, Boston, MA 02115 USA
关键词
D O I
10.1016/j.jtcvs.2007.03.044
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Using a national cancer registry, we determined the postoperative survival of patients with stage IA non-small cell lung cancer in the United States from 1988 to 1997 and identified factors that affect survival. Methods: Within the Surveillance, Epidemiology, and End Result Program database, 10,761 patients were identified as having stage IA non-small cell lung cancer and underwent curative surgical resection from 1988 to 1997. Univariate analyses were performed by the log-rank test to determine predictors of survival, and multivariable analysis was performed by a Cox regression model. Results: Overall 5-year survival was 58%. On univariate analysis, tumor size, gender, age, and extent of resection were significant predictors of survival. Five-year survival of patients with tumors 2.1 to 3.0 cm was lower than that for patients with tumors 2.0 cm or smaller: 55% versus 60% (P < .0001). Men faired significantly worse than women, with a 5-year survival of 53% versus 63% (P < .0001). Patients older than the median age of 67 years had worse 5-year survival than had those under the median age: 52% versus 65% (P < .0001). Patients undergoing sublobar resections showed poorer 5-year survival than patients undergoing anatomic resections: 44% versus 61% (P < .0001). On multivariable analysis with a Cox regression model, all 4 variables remained statistically significant. Conclusion: The survival of patients with stage IA non-small cell lung cancer within the United States is significantly worse than survival reported from single-institution studies. This study identifies 4 factors that may affect survival in resected stage IA non-small cell lung cancer: tumor size, gender, age, and extent of resection.
引用
收藏
页码:850 / 856
页数:7
相关论文
共 23 条
[1]   Survival after pathological stage IA nonsmall cell lung cancer:: Tumor size matters [J].
Birim, Ö ;
Kappetein, AP ;
Takkenberg, JJM ;
van Klaveren, RJ ;
Bogers, AJJC .
ANNALS OF THORACIC SURGERY, 2005, 79 (04) :1137-1141
[2]   Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma [J].
de Perrot, M ;
Licker, M ;
Bouchardy, C ;
Usel, M ;
Robert, J ;
Spiliopoulos, A .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2000, 119 (01) :21-26
[3]   Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease [J].
Gajra, A ;
Newman, N ;
Gamble, GP ;
Abraham, NZ ;
Kohman, LJ ;
Graziano, SL .
LUNG CANCER, 2003, 42 (01) :51-57
[4]   Cancer statistics, 2001 [J].
Greenlee, RT ;
Hill-Harmon, MB ;
Murray, T ;
Thun, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 2001, 51 (01) :15-36
[5]   RANDOMIZED TRIAL OF LOBECTOMY VERSUS LIMITED RESECTION FOR T1 N0 NON-SMALL-CELL LUNG-CANCER [J].
HOLMES, CE ;
RUCKDESCHEL, JC ;
JOHNSTON, M ;
THOMAS, PA ;
DESLAURIERS, J ;
GROVER, FL ;
HILL, LD ;
FELD, R ;
GINSBERG, RJ ;
MOUNTAIN, CF ;
DZUIBAN, S ;
KIELY, M ;
MCKNEALLY, MF ;
MOORES, DWO ;
RAMNES, C ;
WAGNER, H ;
BUNN, P ;
CHU, H ;
DIENHART, D ;
HAZUKA, M ;
KINZIE, J ;
SORENSEN, J ;
VANCE, V ;
BRAUN, T ;
HOPEMAN, A ;
KANE, M ;
RUSS, P ;
WHITMAN, GJR ;
FALL, SM ;
HANSEN, DP ;
HENDERSON, RH ;
MONCRIEF, CL ;
PAULING, F ;
SIMS, J ;
TELL, D ;
WISELYCARR, S ;
ABERNATHY, CM ;
CLARK, DA ;
MCCROSKEY, B ;
MOORE, G ;
MOORE, F ;
MYERS, A ;
WHITE, M ;
BROOKS, RJ ;
BULL, M ;
JOHNSON, FB ;
NEIMYR, M ;
PAQUETTE, FR ;
SACCOMANNO, G ;
LAD, T .
ANNALS OF THORACIC SURGERY, 1995, 60 (03) :615-622
[6]   Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: A single-institution study [J].
Kodama, K ;
Doi, O ;
Higashiyama, M ;
Yokouchi, H .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 114 (03) :347-353
[7]   Intentional limited pulmonary resection for peripheral T1 NO MO small-sized lung cancer [J].
Koike, T ;
Yamato, Y ;
Yoshiya, K ;
Shimoyama, T ;
Suzuki, R .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (04) :924-928
[8]   Lobectomy versus limited resection in T1 N0 lung cancer [J].
Lederle, FA .
ANNALS OF THORACIC SURGERY, 1996, 62 (04) :1249-1249
[9]   INCIDENCE OF LOCAL RECURRENCE AND 2ND PRIMARY TUMORS IN RESECTED STAGE-I LUNG-CANCER [J].
MARTINI, N ;
BAINS, MS ;
BURT, ME ;
ZAKOWSKI, MF ;
MCCORMACK, P ;
RUSCH, VW ;
GINSBERG, RJ .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 109 (01) :120-129
[10]   Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database [J].
Mery, CM ;
Pappas, AN ;
Bueno, R ;
Colson, YL ;
Linden, P ;
Sugarbaker, DJ ;
Jaklitsch, MT .
CHEST, 2005, 128 (01) :237-245